Last reviewed · How we verify
treatment of relapsing forms of multiple sclerosis ms to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability
Approved treatments
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- treatment of relapsing forms of multiple sclerosis ms to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability patent landscape — cliff calendar, originator estates, attackable patents
- treatment of relapsing forms of multiple sclerosis ms to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability treatment landscape brief
- treatment of relapsing forms of multiple sclerosis ms to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability treatment updates RSS
Related
- Treatment landscape: treatment of relapsing forms of multiple sclerosis ms to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability patent cliff · treatment of relapsing forms of multiple sclerosis ms to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing